!!! Free of Charge EQA scheme for 2019 !!!

REWARD: partecipating labs will be included in a Scientific Publications!

EQA Available schemes:

Cloud Desktop

I'm a paragraph. Click here to add your own text and edit me. It’s easy. Just click “Edit Text” or double click me.

EQA Available schemes:

METHODOLOGY PROGRAMS
Germline mutation testing of inherited diseases by Direct sequencing: genotyping

Evaluation of the laboratory ability to correctly identify one or more variants by Sanger sequencing. Sample processing has to be performed with the methods currently used in the diagnostic flow.

Germline mutation testing of inherited diseases by targeted Next-generation sequencing: genotyping

Evaluation of the laboratory ability to correctly identify one or more variants by Sanger sequencing. Sample processing has to be performed with the methods currently used in the diagnostic flow.

PATHOLOGY PROGRAMS
Germline mutation testing of inherited diseases by Direct sequencing: genotyping & interpretation

Evaluation of the laboratory ability to correctly identify one or more variants by Sanger sequencing. Sample processing has to be performed with the methods currently used in the diagnostic flow and the report has to be written in the format required by the respective quality management systems.

Germline mutation testing of inherited diseases by Next-generation sequencing: genotyping & interpretation

Evaluation of the laboratory ability to correctly identify one or more variants by Next-Generation sequencing. Sample processing has to be performed with the methods currently used in the diagnostic flow and the report has to be written in the format required by the respective quality management systems.

Copy number alteration evaluation by targeted real-timePCR: genotyping & interpretation

Evaluation of the laboratory ability to correctly identify one copy number alteration. Sample processing has to be performed with the methods currently used in the diagnostic flow and the report has to be written in the format required by the respective quality management systems.

Evaluation of presence of antibody in patients in Enzyme Replacement Therapy: serum analysis & interpretation

Evaluation of the laboratory ability to correctly identify presence or absence of serum antibodies against beta-glucocerebrosidase. Sample processing has to be performed with the methods currently used in the diagnostic flow and the report has to be written in the format required by the respective quality management systems.

MAGI'S LAB SRL  

 

Address: Via Delle Maioliche 57/D,

38068 Rovereto (TN)  

ITALY

Phone: 0039-0464-420795

© 2019 by MME.